Stock BIOC GLAXOSMITHKLINE S.A.E
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart GlaxoSmithKline S.A.E

Equities

BIOC

EGS38171C012

End-of-day quote Egyptian Exchange
Other stock markets
 18:00:00 2024-05-08 EDT 		5-day change 1st Jan Change
30.13 EGP -0.20% Intraday chart for GlaxoSmithKline S.A.E -3.06% -15.25%
03-04 GlaxoSmithKline S.A.E Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 GlaxoSmithKline S.A.E Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Pharmaceuticals

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
GLAXOSMITHKLINE S.A.E Stock GlaxoSmithKline S.A.E
 53.09M - - - - -
ELI LILLY AND COMPANY Stock Eli Lilly and Company
 684B
NOVO NORDISK A/S Stock Novo Nordisk A/S
 568B
JOHNSON & JOHNSON Stock Johnson & Johnson
 361B
MERCK & CO., INC. Stock Merck & Co., Inc.
 329B
ABBVIE INC. Stock AbbVie Inc.
 284B
  1. Stock Market
  2. Equities
  3. BIOC Stock
  4. Charts GlaxoSmithKline S.A.E
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW